|
CBWD6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.411600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.533800E-01 |
| Normal-vs-Stage2 |
2.911800E-01 |
| Normal-vs-Stage3 |
3.277700E-02 |
| Normal-vs-Stage4 |
2.046000E-01 |
| Stage1-vs-Stage2 |
3.977200E-01 |
| Stage1-vs-Stage3 |
2.094100E-02 |
| Stage1-vs-Stage4 |
2.493400E-01 |
| Stage2-vs-Stage3 |
6.305600E-01 |
| Stage2-vs-Stage4 |
8.994000E-01 |
| Stage3-vs-Stage4 |
7.170400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.681760E-01 |
| Normal-vs-AfricanAmerican |
6.543400E-01 |
| Normal-vs-Asian |
1.115600E-01 |
| Caucasian-vs-AfricanAmerican |
1.447230E-01 |
| Caucasian-vs-Asian |
3.020800E-01 |
| AfricanAmerican-vs-Asian |
3.323600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.942100E-03 |
| Normal-vs-Female |
3.570400E-01 |
| Male-vs-Female |
3.71839999999679E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.908200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.926000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.523440E-01 |
| Normal-vs-Age(81-100Yrs) |
8.754000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.549000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.253000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.579800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.322200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.344000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.048000E-02 |
| Normal-vs-Grade 2 |
1.554570E-01 |
| Normal-vs-Grade 3 |
5.473800E-01 |
| Normal-vs-Grade 4 |
2.735800E-03 |
| Grade 1-vs-Grade 2 |
6.468100E-02 |
| Grade 1-vs-Grade 3 |
7.485800E-02 |
| Grade 1-vs-Grade 4 |
1.949810E-02 |
| Grade 2-vs-Grade 3 |
3.832400E-01 |
| Grade 2-vs-Grade 4 |
1.672490E-02 |
| Grade 3-vs-Grade 4 |
5.135300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.547000E-01 |
| Normal-vs-ccB subtype |
3.656000E-03 |
| ccA subtype-vs-ccB subtype |
3.013600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.633800E-01 |
| Normal-vs-N1 |
4.626400E-02 |
| N0-vs-N1 |
1.341210E-01 |
|
|
